Published in Nat Med on June 21, 2009
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol (2012) 2.81
The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One (2011) 1.96
The cell biology of receptor-mediated virus entry. J Cell Biol (2011) 1.75
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog (2013) 1.52
PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature (2017) 1.48
Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One (2011) 1.45
Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol (2011) 1.44
Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J (2009) 1.36
Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem (2012) 1.33
Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol (2013) 1.32
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol (2012) 1.28
Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol (2011) 1.26
Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol (2010) 1.25
Enterovirus infections of the central nervous system. Virology (2011) 1.24
Viral and host proteins involved in picornavirus life cycle. J Biomed Sci (2009) 1.24
Host factors in enterovirus 71 replication. J Virol (2011) 1.19
Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol (2012) 1.16
Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol (2013) 1.14
The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments. Virol J (2010) 1.12
The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem (2010) 1.12
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One (2012) 1.12
Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11
Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One (2013) 1.10
Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One (2013) 1.09
Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog (2013) 1.07
A single nucleotide in stem loop II of 5'-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One (2011) 1.07
The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog (2015) 1.03
Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog (2010) 1.02
Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol (2014) 1.02
Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol (2012) 1.01
Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A (2013) 0.99
A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J Virol (2013) 0.99
Enterovirus 71 infection of monocytes with antibody-dependent enhancement. Clin Vaccine Immunol (2010) 0.98
Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog (2014) 0.98
Neurotropic Enterovirus Infections in the Central Nervous System. Viruses (2015) 0.98
Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A (2013) 0.98
Human SCARB2-mediated entry and endocytosis of EV71. PLoS One (2012) 0.98
Structural analysis of coxsackievirus A7 reveals conformational changes associated with uncoating. J Virol (2012) 0.98
Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell (2014) 0.95
Circulating HFMD-associated coxsackievirus A16 is genetically and phenotypically distinct from the prototype CV-A16. PLoS One (2014) 0.95
Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus. J Virol (2011) 0.94
Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol (2012) 0.94
Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J Gen Virol (2014) 0.93
Receptors identified for hand, foot and mouth virus. Nat Med (2009) 0.93
Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J (2013) 0.92
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J (2011) 0.92
Strategies to develop antivirals against enterovirus 71. Virol J (2013) 0.92
Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection. PLoS One (2013) 0.92
Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol (2015) 0.91
Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics (2014) 0.91
COPI is required for enterovirus 71 replication. PLoS One (2012) 0.89
Inhibition of enterovirus 71 by adenosine analog NITD008. J Virol (2014) 0.89
Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS One (2014) 0.88
Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J Biomed Sci (2014) 0.88
Cellular receptors for human enterovirus species a. Front Microbiol (2012) 0.87
Immunological and biochemical characterization of coxsackie virus A16 viral particles. PLoS One (2012) 0.86
The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo. Emerg Microbes Infect (2014) 0.85
Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci (2014) 0.85
Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol (2012) 0.85
Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation. J Virol (2012) 0.85
Receptors for enterovirus 71. Emerg Microbes Infect (2014) 0.83
A neonatal gnotobiotic pig model of human enterovirus 71 infection and associated immune responses. Emerg Microbes Infect (2014) 0.83
Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution. J Virol (2015) 0.82
Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci (2014) 0.82
Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses (2012) 0.82
Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells. J Virol (2011) 0.82
Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J Virol (2014) 0.81
Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity. J Virol (2015) 0.81
The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol J (2014) 0.81
Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling. PLoS One (2014) 0.81
Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody. PLoS Pathog (2016) 0.80
Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABC. Viruses (2016) 0.80
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine. PLoS Negl Trop Dis (2013) 0.80
Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice. Med Microbiol Immunol (2013) 0.80
Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles. J Virol (2015) 0.80
The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. J Virol (2014) 0.80
Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS One (2015) 0.80
Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J Virol (2013) 0.80
Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry. J Virol (2015) 0.80
Antiviral activity of micafungin against enterovirus 71. Virol J (2016) 0.80
Nuclear Protein Sam68 Interacts with the Enterovirus 71 Internal Ribosome Entry Site and Positively Regulates Viral Protein Translation. J Virol (2015) 0.79
EV71-infected CD14(+) cells modulate the immune activity of T lymphocytes in rhesus monkeys. Emerg Microbes Infect (2013) 0.79
Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother (2015) 0.79
The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate. PLoS Pathog (2015) 0.78
Enterovirus 71 infection and neurological complications. Korean J Pediatr (2016) 0.78
Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis (2015) 0.78
A Metabolomics Profiling Study in Hand-Foot-and-Mouth Disease and Modulated Pathways of Clinical Intervention Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. Evid Based Complement Alternat Med (2013) 0.78
Enterovirus 71 virion-associated galectin-1 facilitates viral replication and stability. PLoS One (2015) 0.78
Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy. PLoS One (2013) 0.78
PSGL-1: A New Player in the Immune Checkpoint Landscape. Trends Immunol (2017) 0.78
Therapeutic and prevention strategies against human enterovirus 71 infection. World J Virol (2015) 0.77
Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate. Virusdisease (2013) 0.77
Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). Emerg Microbes Infect (2016) 0.76
The cellular receptor for enterovirus 71. Protein Cell (2014) 0.76
Transcriptome analysis reveals dynamic changes in coxsackievirus A16 infected HEK 293T cells. BMC Genomics (2017) 0.76
Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice. Biomed Res Int (2014) 0.75
Polio, still lurking in the shadows. J Neurosci (2013) 0.75
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease. PLoS Pathog (2016) 0.75
Antibodies to P-selectin glycoprotein ligand-1 block dendritic cell-mediated enterovirus 71 transmission and prevent virus-induced cells death. Virulence (2015) 0.75
An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med (1999) 11.06
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev (2002) 5.63
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell (2000) 3.95
Expression cloning of a functional glycoprotein ligand for P-selectin. Cell (1993) 3.90
Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis (2003) 2.36
Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem (1996) 2.26
Picornavirus-receptor interactions. Trends Microbiol (2002) 2.23
Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis (2003) 2.00
Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol (2002) 1.78
P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood (1996) 1.69
Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol (2007) 1.61
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
The molecular basis of mouse adaptation by human enterovirus 71. J Gen Virol (2008) 1.50
Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol (2004) 1.43
The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol (2008) 1.40
Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol (2008) 1.38
Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol (2002) 1.33
Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol (2000) 1.25
Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol (2007) 1.14
Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol (2004) 1.13
Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol (2006) 1.03
Outbreak news. Enterovirus, China. Wkly Epidemiol Rec (2008) 0.98
Isolation of T-cell antigens by retrovirus-mediated expression cloning. Methods Mol Biol (2000) 0.97
Binding of function-blocking mAbs to mouse and human P-selectin glycoprotein ligand-1 peptides with and without tyrosine sulfation. J Leukoc Biol (2002) 0.91
Usage of myeloma and panning in retrovirus-mediated expression cloning. Anal Biochem (2003) 0.91
Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A (2005) 14.78
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol (2007) 8.98
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology (2003) 7.35
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science (2002) 5.71
The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology (2004) 4.95
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A (2006) 4.54
Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol (2006) 3.33
Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19
Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int (2004) 3.06
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet (2005) 3.01
Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol (2008) 2.74
Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology (2008) 2.66
Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol (2005) 2.63
Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis (2005) 2.55
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology (2008) 2.45
Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol (2005) 2.33
Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem (2004) 2.32
Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis (2012) 2.26
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology (2007) 2.25
Cell culture and infection system for hepatitis C virus. Nat Protoc (2006) 2.14
Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology (2006) 2.14
DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J Virol (2007) 2.12
Sodium intake and risk of death from stroke in Japanese men and women. Stroke (2004) 2.10
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol (2006) 1.99
Genetic and antigenic diversity among noroviruses. J Gen Virol (2006) 1.91
Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ (2004) 1.90
Replication of a hepatitis C virus replicon clone in mouse cells. Virol J (2006) 1.90
Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J (2006) 1.89
Sleep disturbance and onset of type 2 diabetes. Diabetes Care (2004) 1.88
Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol (2005) 1.86
Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol (2006) 1.86
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology (2010) 1.85
Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology (2007) 1.82
Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A (2009) 1.82
Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology (2006) 1.81
Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol (2002) 1.78
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol (2003) 1.76
The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology (2005) 1.75
Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol (2006) 1.72
Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J Biochem (2006) 1.71
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol (2007) 1.69
Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice. Gastroenterology (2013) 1.67
Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 1.66
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol (2008) 1.65
Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol (2008) 1.65
Processing of hepatitis C virus core protein is regulated by its C-terminal sequence. J Med Virol (2003) 1.64
CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol (2007) 1.61
Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol (2005) 1.60
Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy (2009) 1.60
Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J Hepatol (2010) 1.58
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol (2005) 1.53
Development of hepatitis C virus genotype 3a cell culture system. Hepatology (2014) 1.53
Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. J Clin Virol (2011) 1.48
Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A (2007) 1.45
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol (2005) 1.43
Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol (2004) 1.43
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
Hepatitis C viral life cycle. Adv Drug Deliv Rev (2007) 1.41
Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol (2004) 1.40
Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol (2009) 1.40
Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol (2010) 1.40
Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem (2010) 1.40
Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology (2009) 1.40
Anatomical analysis of different hemispherotomy procedures based on dissection of cadaveric brains. J Neurosurg (2002) 1.39
Relation between VE/VCO2 slope and maximum phonation time in chronic heart failure patients. Medicine (Baltimore) (2014) 1.39
Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol (2010) 1.39
Primary amenorrhea accompanied by adrenal adenoma: start of menarche soon after tumor resection. Intern Med (2002) 1.37
Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol (2008) 1.36
Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J Virol (2005) 1.35
Molecular typing and epidemiology of non-polio enteroviruses isolated from Yunnan Province, the People's Republic of China. J Med Virol (2008) 1.34
A norovirus protease structure provides insights into active and substrate binding site integrity. J Virol (2005) 1.34
The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog (2010) 1.33
Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology (2008) 1.32
Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol (2005) 1.31
Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology (2002) 1.30